Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
104.72
-1.19 (-1.12%)
At close: Dec 12, 2025, 4:00 PM EST
104.80
+0.08 (0.08%)
After-hours: Dec 12, 2025, 5:56 PM EST
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.14 billion as of December 12, 2025. Its market cap has increased by 18.94% in one year.
Market Cap
8.14B
Enterprise Value
7.20B
1-Year Change
18.94%
Ranking
Category
Stock Price
$104.72
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.14B, an increase of 922.47%. That is a compound annual growth rate of 70.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 8.14B | 46.32% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |